Inhalant Abuse: Supporting Broad-Based Research Approaches (R03)
The summary for the Inhalant Abuse: Supporting Broad-Based Research Approaches (R03) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Inhalant Abuse: Supporting Broad-Based Research Approaches (R03): - The goal of this funding opportunity announcement is to encourage research on all aspects of inhalant abuse (i.e., epidemiology; prevention, treatment and service delivery; antecedents, consequences and neurobiological mechanisms).-Inhalants are volatile substances that produce chemical vapors that can be inhaled to induce a psychoactive or mind-altering effect. Prevalence data indicate that inhalant abuse continues to be a major public health concern among grade school children, adolescents and some adults. Inhalants pose a particular hazard since they are readily accessible, legal and inexpensive. They often are abused by young children and can be highly toxic or lethal. The National Institute on Drug Abuse (NIDA) invites qualified researchers to submit research grant applications aimed at improving our understanding of inhalant abuse, particularly among pre-adolescent and adolescent populations.-The total amount to be awarded is contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. -This funding opportunity utilizes the R03 mechanism and runs in parallel with FOAs of identical scientific scope (PA-05-099) that solicits applications under the traditional research project grant (R01) and PA-06-327 that solicits applications under the exploratory/developmental grant (R21) mechanism.-The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.
Federal Grant Title: | Inhalant Abuse: Supporting Broad-Based Research Approaches (R03) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-06-328 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Apr 06, 2006 |
Creation Date: | Oct 03, 2007 |
Archive Date: | Oct 07, 2008 |
Total Program Funding: | |
Maximum Federal Grant Award: | $50,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Special district governments Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) State governments
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Faith-based or community-based organizations
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
- • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
- • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...